Riccardo De Paola

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsMedical bacteriologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2026
ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections.

|Mar 28, 2026
Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma.

Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola

|Mar 17, 2026
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis.

Milo Gatti, Riccardo De Paola, Beatrice Giorgi

|Jan 28, 2026
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion.

Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola

|Aug 28, 2025
TDM-Based Approach for Properly Managing Intravenous Isavuconazole Treatment in a Complex Case Mix of Critically Ill Patients.

Milo Gatti, Matteo Rinaldi, Riccardo De Paola

Pageof 1

Frequent Collaborators

5 joint publications

Milo Gatti

5 joint publications

Federico Pea

2 joint publications

Beatrice Giorgi

1 joint publications

Tommaso Tonetti